Development of a generic physiologically based pharmacokinetic model to predict clinical pharmacokinetics and assess drug-drug interaction risks for valine-citrulline-monomethyl auristatin E-based antibody-drug conjugates.
Study designOther primary literature
SubjectHuman
Abstract
cc by 以外(cc by-nc / cc by-nc-nd / NONE 等)は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。
MeSH
DOI 10.1016/j.dmd.2026.100289
PMID 42066734
View source →